US president Joe Biden has called for a scheduling review of cannabis. Changing the schedule (rescheduling) or removing a controlled substance like cannabis completely from the schedules in the CSA (descheduling) can be done in two ways – by legislation or by administrative action. Legislation obviously requires Congress to pass a bill, but administrative action can be commenced at the request of certain agencies, like the Department of Health and Human Services (DHHS), as is the case here.

This report will examine the procedure, potential outcomes, and implications of this scheduling review.

Free Sample
I'm already a subscriber

Anthony Traurig

Head legal analyst
Anthony focuses on regulatory developments and legal analysis in the US. Anthony has a BA in political science from North Carolina State University and a JD from Charleston School of Law (South Carolina), where he was a senior editor on the law review. He practised law for several years in the United States as a litigator.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization